AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Knowing when to reassess your financial plan is key to success. Stay informed about the right times to make adjustments.
23,689 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Federal prosecutors dismantle a sprawling fraud machine that used mass texting, scripted pitches, and fake crypto pla...
Two big reasons explain why the fear around IBM's COBOL future might be overstated. This piece breaks down why COBOL ...
A small-cap data services company sparked May’s AI rally, with Innodata surging nearly 150% after a solid earnings re...
SpaceX expanded through a 2026 all-stock deal with xAI, creating a $1.25 trillion powerhouse. This report profiles th...
Oil prices slide and spike in turn as Strait of Hormuz tensions flare. Trump’s time running avoid weighs on markets a...
The inaugural Fortune-style Crypto 40 lays out who truly moves the crypto economy in 2026, led by Uniswap in DeFi and...
A Federal Reserve study shows the price surge hitting low-income households hardest, revealing a widening gap in ener...
OpenAI's finance chief says AI-tool fluency is now a baseline for finance hires, with Codex playing a key role as dem...
A retiree netting $36,000 a year from rentals faces ongoing taxation on most of his Social Security benefits due to p...
Oil prices march upward again as tensions between the U.S. and Iran flare, pushing Brent above $80 and complicating i...
A moment at Paris Fashion Week turned into a financial lesson for readers worldwide. This article breaks down how a v...